This HTML5 document contains 183 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n11http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n7http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q33592137
rdf:type
wikibase:Item
schema:description
artigo científico (publicado na 2017) 2017年论文 vitskapeleg artikkel articolo scientifico научни чланак artykuł naukowy 2017 թվականի մարտին հրատարակված գիտական հոդված 2017年论文 2017 թուականի Մարտին հրատարակուած գիտական յօդուած наукова стаття, опублікована в березні 2017 مقالهٔ علمی 2017 nî lūn-bûn wetenschappelijk artikel מאמר מדעי scienca artikolo 2017年论文 ২০১৭-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ vetenskaplig artikel artigo científico (publicado na 2017) 2017年論文 επιστημονικό άρθρο 2017年论文 mokslinis straipsnis bài báo khoa học مقالة علمية artikull shkencor 2017年論文 article scientific vedecký článok научна статия 2017년 논문 teaduslik artikkel artículu científicu espublizáu en 2017 научни чланак artigo científico tudományos cikk bilimsel makale 2017年の論文 article científic 2017年論文 naučni članak سائنسی مضمون мақолаи илмӣ scientific article tieteellinen artikkeli videnskabelig artikel (udgivet 2017) 2017年論文 мақолаи илмӣ articol științific 2017年论文 ശാസ്ത്രപ്രബന്ധം​ artículo científico publicado en 2017 სამეცნიერო სტატია artikulong pang-agham vědecký článek article scientifique (publié 2017) 2017年論文 vitenskapelig artikkel научная статья wissenschaftlicher Artikel 2017年论文 บทความทางวิทยาศาสตร์
p:P577
wds:Q33592137-A7C3A5C3-2F6B-4EDD-9B1E-CC122D52A1B3
wdt:P577
2017-03-06T00:00:00Z
p:P407
wds:Q33592137-87420B85-EE72-4588-A78F-DF9458518E19
wdt:P407
wd:Q1860
p:P2860
wds:Q33592137-3D0D5EFB-5EF8-4B0C-8BA4-C76730CCDFCB wds:Q33592137-2E02CC35-1085-489E-9C81-263B68BEC85B wds:Q33592137-30F63B7C-A865-4DB1-99DF-FB31337C1955 wds:Q33592137-21301A4A-1B63-4BC0-9AC7-9F35BCBDDB51 wds:Q33592137-16EB3B45-F004-4876-AF90-9E29804F2BBA wds:Q33592137-959A3565-BDBA-4B44-8161-453F1C49DAFA wds:Q33592137-A3C813AF-B8CD-463A-8913-725C4ECED155 wds:Q33592137-913EE4C1-11C6-458F-AF3B-CFF6A36A171C wds:Q33592137-6A4BBB8D-06C0-4542-BCE8-4DA23C9D73A0 wds:Q33592137-6EC92DD3-CD03-4E1A-AA60-FB4A7F04FFD2 wds:Q33592137-4E3DD7D5-F585-4324-8964-69A47E3B5B83 wds:Q33592137-5639BD6F-B058-4586-BE5C-51BA95871F44 wds:Q33592137-57476FD4-208F-46B7-BA46-604512905D1D wds:Q33592137-D3A88767-288B-4DDA-AF0B-80FC2C7BFFAA wds:Q33592137-DE7005CC-BDB2-4823-A880-CED5582E70AA wds:Q33592137-DF857832-B26B-484E-9B5B-0C966C0C8755 wds:Q33592137-C1E6D743-6350-4456-93DD-0C6E1BF2861A wds:Q33592137-CB2470A5-6270-485A-8EC1-7A8B99A71CA6 wds:Q33592137-C1DB1AD3-A27B-4B6E-9753-2DDE11460AB4 wds:Q33592137-B030732F-FEF0-4EB7-9C87-BADF2E86D387 wds:Q33592137-B2B8BFA7-E3FE-4ED9-A982-74770FA86390 wds:Q33592137-FED18246-2BEB-4365-91BB-60B7F2092C23 wds:Q33592137-E013EA23-E2BF-4416-80A4-FF9800B2E38E wds:Q33592137-E8DFD891-C036-4D59-BA32-DCD29B457AD5 wds:Q33592137-F06839CB-12C4-47F3-BFF8-34ACFF576E4A wds:Q33592137-F3F94ED0-2CE5-44D7-A242-862BB6D16C34 wds:Q33592137-0C4AA233-237B-40E9-B6AB-3E6FB2BC2503 wds:Q33592137-13EBAC82-9582-453E-B205-6EC397CC2ECB wds:Q33592137-15414D55-AB13-48FF-91F1-701EDDEADDAC
wdt:P2860
wd:Q39538901 wd:Q43941129 wd:Q45988713 wd:Q85190909 wd:Q54028721 wd:Q85344681 wd:Q31454538 wd:Q86445949 wd:Q46142069 wd:Q43872841 wd:Q37799416 wd:Q42283388 wd:Q34067962 wd:Q38067153 wd:Q35077844 wd:Q87028117 wd:Q60781903 wd:Q48855164 wd:Q50439470 wd:Q34537053 wd:Q24234527 wd:Q72586689 wd:Q41142138 wd:Q24654269 wd:Q36345701 wd:Q86669020 wd:Q86475977 wd:Q85592005 wd:Q57506046
p:P2093
wds:Q33592137-31A57FD6-2479-48C8-9625-16E8726C53A9 wds:Q33592137-3AEB7E6E-F93D-4F33-AC4D-842D5AA25EC7 wds:Q33592137-19EEB501-345C-4863-A39D-57A918544FAF wds:Q33592137-22645D98-DD26-45BE-A656-4C3B365F2A04 wds:Q33592137-27A6673C-3F00-4886-BDFA-B19005917C00 wds:Q33592137-D096C03C-63CB-4A67-B39F-C652D7692514 wds:Q33592137-A7CB4E24-7043-4863-BE66-983D684A6DD6 wds:Q33592137-AD192973-A7F3-47FC-ADB3-8DFED7E329BD wds:Q33592137-89A52581-2087-44FA-83B7-1B2604B46A3F wds:Q33592137-888DD079-C269-4521-B29A-81D3C3871049 wds:Q33592137-597B97A5-D21A-4769-8111-03E21A442567 wds:Q33592137-70AF4723-3EA2-40E8-A8A1-E3A366685E2D
wdt:P2093
Gudula Kirtschig Margaret Childs Joanne R Chalmers Hywel C Williams Diane Whitham Fenella Wojnarowska Shernaz Walton UK Dermatology Clinical Trials Network BLISTER Study Group Karen Harman Thomas R Godec Andrew J Nunn Anna Chapman
rdfs:label
Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial
skos:prefLabel
Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial
schema:name
Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial
p:P50
wds:Q33592137-BA7BB370-DBA8-40E8-9B07-DEA97136445D wds:Q33592137-CA5FD34F-0E4A-46E2-A467-13C3FD28F3F4
wdt:P50
wd:Q48026367 wd:Q54100456
p:P1476
wds:Q33592137-7EF48791-6209-457A-9BA2-8782DF75E766
wdt:P1476
Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial
p:P304
wds:Q33592137-4B7666E5-90AD-4DD7-A39F-980A0B0371C3
wdt:P304
1630-1638
p:P31
wds:Q33592137-20F02F95-03D3-4601-ADED-40970B0D13E3
wdt:P31
wd:Q13442814
p:P921
wds:Q33592137-368E51AE-CA4A-4113-B408-94C863D73815 wds:Q33592137-9F4C0F03-C540-4CAB-A486-ECD4DD1367D7
wdt:P921
wd:Q422442 wd:Q1004647
p:P698
wds:Q33592137-4B2CDF45-2EAE-4614-9D11-FA6E3A7F3939
wdtn:P698
n7:28279484
wdt:P698
28279484
p:P1433
wds:Q33592137-22542A06-1BB1-499F-B121-7F194EEF4CC1
wdt:P1433
wd:Q939416
p:P433
wds:Q33592137-DE54A664-FA87-4282-BF8B-ABA5258A62F4
p:P478
wds:Q33592137-1A50B22C-ACC7-45B3-B140-726F9C945280
wdt:P433
10079
wdt:P478
389
p:P356
wds:Q33592137-B31D8E2F-7C34-4C4D-8F9F-0D8C6DA03399
wdtn:P356
n11:S0140-6736(17)30560-3
wdt:P356
10.1016/S0140-6736(17)30560-3
p:P932
wds:Q33592137-BCE073A7-96E6-4268-B31C-2B15523A9CD8
wdt:P932
5400809